Pearce Tillman 4
4 · THRESHOLD PHARMACEUTICALS INC · Filed May 24, 2013
Insider Transaction Report
Form 4
Pearce Tillman
Chief Medical Officer
Transactions
- Sale
Common Stock
2013-05-22$5.63/sh−20,000$112,660→ 0 total - Exercise/Conversion
Common Stock
2013-05-22$3.46/sh+20,000$69,200→ 20,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2012-02-16−20,000→ 230,000 totalExercise: $3.46Exp: 2022-02-16→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]25% of the shares underlying the Option shall vest and become exercisable on February 16, 2013. Thereafter the remaining shares will vest and become exercisable at a rate of 1/36th per month.